Listed as “Until”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Until researches technology for limiting ice formation during vitrification.
Until is developing technology intended to limit ice formation during the vitrification process, as part of its research and development. Its work spans perfusion, cryoprotectants, cooling, rewarming, and assessment of organ health.
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Until”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.